Mays Cancer Center at UT Health San Antonio melanoma expert Monte Shaheen, MD, was part of a team of investigators that conducted a phase II clinical trial to determine the efficacy and safety of administering the immunotherapy drug pembrolizumab before and after surgery in high-risk melanoma patients.

Jane Mattei, MD, joined Mays Cancer Center as a medical oncologist specializing in melanoma and other skin cancers and Gary Lewis, MD, has started as a radiation oncologist specializing in gynecologic brachytherapy and head and neck cancers.

While skin cancer can affect anyone, people with fair skin are twice as likely to develop skin cancer than those with darker skin complexions.